Posted on October 28, 2020 by Sitemaster
Perhaps unsurprisingly, your sitemaster was a little distracted on March 9 this year (by both the start of the COVID-19 chaos and by his birthday) and so he utterly missed what appears to be a rather important paper on the use of 5α-reductase inhibitors (5-ARIs) in men on active surveillance (AS) for management of low-risk forms of prostate cancer.
… READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: 5-ARI, active, AS, Prevention, progression, surveillance | 2 Comments »
Posted on November 20, 2019 by Sitemaster
There have long been suggestions that men already diagnosed with and receiving treatment for diabetes are at lower risk for a subsequent diagnosis of prostate cancer than non-diabetics. However, a very large, new, epidemiological analysis seems to suggest strongly that this may not be the case at all. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: ant-diabetic, diabetes, medication, Prevention, risk | 3 Comments »
Posted on September 6, 2019 by Sitemaster
The Prostate Cancer Foundation (PCF) has recently issued a new “booklet” (it’s about 90 pages in length) entitled, The Science of Living Well, Beyond Cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Prevention | Tagged: diet, exercise, lifestyle, living, Prevention, well | 1 Comment »
Posted on September 6, 2019 by Sitemaster
Well, maybe, … at least among men living in in the Miyagi and Ohsaki prefectures, in Japan. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: Japan, mushrooms, Prevention, risk | Leave a comment »
Posted on March 5, 2019 by Sitemaster
A newly published article — and an associated editorial — in the Annals of Internal Medicine has addressed the possible benefits of taking low-dose aspirin as a method to prevent the progression of newly diagnosed prostate cancer. … READ MORE …
Filed under: Uncategorized | Tagged: aspirin, outcome, Prevention, progression, risk | 7 Comments »
Posted on January 3, 2019 by Sitemaster
Two sets of results from a major trial focused on the use of supplements to prevent cancer and heart disease are published today in the New England Journal of Medicine. … READ MORE …
Filed under: Diagnosis, Prevention | Tagged: calciferol, cancer, disease, fatty acid, heart, marine n-3, omega-3, Prevention, vitamin D | 12 Comments »
Posted on December 1, 2018 by Sitemaster
As our regular readers will be well aware, there have been a number of published papers suggesting associations between the use of statins and other lipid-lowering agents and risk for diagnosis with and progression of prostate cancer over time. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: agent, lipid, lowering, Prevention, statin | 3 Comments »
Posted on November 11, 2018 by Sitemaster
Two sets of data from the 5-year-long VITamin D and OmegA-3 TriaL (VITAL) were published this week in the New England Journal of Medicine. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: acid, fatty, omega, Prevention, vitamin D | 9 Comments »
Posted on October 22, 2018 by Sitemaster
Clifton Leaf is a cancer survivor. He is also the Editor-in-Chief of Fortune magazine. And he has long argued that we may not be making the most astute decisions about how we are trying to find “the best” and “the rightest” ways to diagnose, treat, and manage cancer. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Prevention, Treatment | Tagged: Diagnosis, Prevention, risk, Treatment | 7 Comments »
Posted on June 13, 2018 by Sitemaster
Something that most of us seem to have managed to “miss” at the American Urological Association (AUA) annual meeting in San Francisco in May was an update from Dr. Ian Thompson on the 25-year outcomes of the Prostate Cancer Prevention Trial (PCPT). It has the potential to be rather important! … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: Diagnosis, finasteride, Prevention, risk | 17 Comments »
Posted on June 1, 2018 by Sitemaster
In an incidentally timely manner, the May issue of Annals of Oncology carries a systematic review and meta-analysis of data on physical activity and risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk | Tagged: activity, Diagnosis, exercise, physical, Prevention, progression, risk | 1 Comment »
Posted on March 2, 2018 by Sitemaster
It should come as no great surprise to anyone that one’s level of physical activity is not necessarily linked, on its own, to one’s risk for diagnosis with prostate cancer. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: Diagnosis, exercise, Prevention, risk | Leave a comment »
Posted on November 7, 2017 by Sitemaster
Today’s “hot news story” in the cancer world is that a very widely used drug called warfarin (often still known as Coumadin) may be able to protect people from the risks of getting diagnosed with at least some cancers. But … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: anticoagulant, Coumadin, Prevention, risk, warfarin | 2 Comments »
Posted on November 15, 2016 by Sitemaster
The question of whether or not to take a statin to either prevent or actually help in the treatment of prostate cancer has potentially just become moot for many men in America … thanks to new guidance from the US Preventive Services Task Force (USPSTF). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: Prevention, risk, statin, Treatment | 7 Comments »
Posted on November 4, 2016 by Sitemaster
A recent review article in the journal Nature Reviews: Urology has concluded that, while we are learning a lot more about the potential role(s) of statins in the prevention and management of prostate cancer, we still have no definitive evidence of their value. … READ MORE …
Filed under: Management, Prevention, Risk, Treatment | Tagged: delay, Prevention, progression, risk, statin | 3 Comments »